CSL Limited (CSLLY)
OTCMKTS · Delayed Price · Currency is USD
65.51
-0.35 (-0.53%)
Sep 19, 2025, 3:58 PM EDT
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $63.34 billion as of September 19, 2025. Its market cap has decreased by -34.49% in one year.
Market Cap
63.34B
Enterprise Value
74.82B
Revenue
15.56B
Ranking
n/a
PE Ratio
21.10
Stock Price
$65.51
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 63.34B, an increase of 27,421.16%. That is a compound annual growth rate of 19.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 63.34B | -24.93% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | 99.40B | 13.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Tian'an Technology Group | 719.18M |
| Elite Pharmaceuticals | 697.08M |
| Glass House Brands | 575.59M |
| Northwest Biotherapeutics | 378.51M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 352.05M |
| American Oncology Network | 340.34M |